Microglial exosomes facilitate α-synuclein transmission in Parkinson’s disease
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Accumulation of neuronal α-synuclein is a prominent feature in Parkinson’s disease. More recently, such abnormal protein aggregation has been reported to spread from cell to cell and exosomes are considered as important mediators. The focus of such research, however, has been primarily in neurons. Given the increasing recognition of the importance of non-cell autonomous-mediated neurotoxicity, it is critical to investigate the contribution of glia to α-synuclein aggregation and spread. Microglia are the primary phagocytes in the brain and have been well-documented as inducers of neuroinflammation. How and to what extent microglia and their exosomes impact α-synuclein pathology has not been well delineated. We report here that when treated with human α-synuclein preformed fibrils, exosomes containing α-synuclein released by microglia are fully capable of inducing protein aggregation in the recipient neurons. Additionally, when combined with microglial proinflammatory cytokines, these exosomes further increased protein aggregation in neurons. Inhibition of exosome synthesis in microglia reduced α-synuclein transmission. The in vivo significance of these exosomes was demonstrated by stereotaxic injection of exosomes isolated from α-synuclein preformed fibrils treated microglia into the mouse striatum. Phosphorylated α-synuclein was observed in multiple brain regions consistent with their neuronal connectivity. These animals also exhibited neurodegeneration in the nigrostriatal pathway in a time-dependent manner. Depleting microglia in vivo dramatically suppressed the transmission of α-synuclein after stereotaxic injection of preformed fibrils. Mechanistically, we report here that α-synuclein preformed fibrils impaired autophagy flux by upregulating PELI1, which in turn, resulted in degradation of LAMP2 in activated microglia. More importantly, by purifying microglia/macrophage derived exosomes in the CSF of Parkinson’s disease patients, we confirmed the presence of α-synuclein oligomer in CD11b+ exosomes, which were able to induce α-synuclein aggregation in neurons, further supporting the translational aspect of this study. Taken together, our study supports the view that microglial exosomes contribute to the progression of α-synuclein pathology and therefore, they may serve as a promising therapeutic target for Parkinson’s disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Microglia-derived exosomes have also been shown to carry and transfer pathogenic α-syn species, potentially further contributing to this spread [158].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [158]
The cited source says what the claim attributes to it.
In the citing paper
“Ultimately, the activation of microglia by these protein aggregates creates a feed-forward vicious cycle that aggravates neurodegeneration as activated microglia contribute to the propagation of tau, Aβ, α-synuclein, and TDP-43 into unaffected brain regions.159–164”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [163]
The cited source says what the claim attributes to it.
In the citing paper
“α-synuclein can also activate glial cells by binding to TLR261,294,295 and enhance the spreading of α-synuclein.70,296”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [296]
The cited source says what the claim attributes to it.
In the citing paper
“They achieved this by isolating exosomes derived from microglia/macrophages in the CSF of PD patients. In doing so, they successfully detected the presence of α-syn oligomer in CD11b + exosomes.”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [148]
The cited source says what the claim attributes to it.
In the citing paper
“Another research conducted by Guo et al. showed that microglial exosomes contribute to the progression of α-syn pathology [148].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [148]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ngolab, J., Trinh, I., Rockenstein, E., Mante, M., Florio, J., Trejo, M., Masliah, D., Adame, A., Masliah, E., & Rissman, R. A. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0445-5 · Cited by 200
RetractedCeramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes
Trajkovic, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F., Schwille, P., Brügger, B., & Simons, M. (2008) · Science · doi:10.1126/science.1153124 · Cited by 3,627
Extracellular vesicles: biology and emerging therapeutic opportunities
EL Andaloussi, S., Mäger, I., Breakefield, X. O., & Wood, M. J. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3978 · Cited by 3,571
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 1×
“Autophagy is a vital pathway by which a-syn is degraded (Webb et al., 2003; Cuervo et al., 2004; Lee et al., 2004).”
BackgroundElmore, M. R. P., Najafi, A. R., Koike, M. A., Dagher, N. N., Spangenberg, E. E., Rice, R. A., Kitazawa, M., Matusow, B., Nguyen, H., West, B. L., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.040 · Cited by 1,968
Depletion of microglia and inhibition of exosome synthesis halt tau propagation
Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., Butovsky, O., Kügler, S., & Ikezu, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4132 · Cited by 1,591
Volpicelli-Daley, L. A., Luk, K. C., Patel, T. P., Tanik, S. A., Riddle, D. M., Stieber, A., Meaney, D. F., Trojanowski, J. Q., & Lee, V. M.-Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.033 · Cited by 1,569
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437
Research works printed but not linked: 1
- Yun X, Guoxin Z, Chao H, Kai M, Xingfang G, Fang W, et al. Microglia as modulators of exosomal alpha-synuclein transmission. Cell Death Dis 2019; 10: 174. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI · Paper page
Cited by
Items 201–300 of 553
Microglia Process α‐Synuclein Fibrils and Enhance their Pathogenicity in a TREM2‐Dependent Manner
Xiong, M., Xia, D., Yu, H., Meng, L., Zhang, X., Chen, J., Tian, Y., Yuan, X., Niu, X., Nie, S., et al. (2024) · Advanced Science · doi:10.1002/advs.202413451 · Cited by 26
Targeting mitochondria-regulated ferroptosis: A new frontier in Parkinson's disease therapy
Wang, W., Thomas, E. R., Xiao, R., Chen, T., Guo, Q., Liu, K., Yang, Y., & Li, X. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110439 · Cited by 24
Jung, Y. H., Jo, H. Y., Kim, D. H., Oh, Y. J., Kim, M. H., Na, S., Song, H., & Lee, H. J. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s513816 · Cited by 23
Central Nervous System Cell‐Derived Exosomes in Neurodegenerative Diseases
Tian, Y., Fu, C., Wu, Y., Lu, Y. W., Liu, X., & Yunling, Z. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9965564 · Cited by 24
Wang, L., Lu, K., Lou, X., Zhang, S., Song, W., Li, R., Geng, L., & Cheng, B. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110762 · Cited by 23
Repurposing of pexidartinib for microglia depletion and renewal
Weyer, M.-P., Strehle, J., Schäfer, M. K. E., & Tegeder, I. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108565 · Cited by 25
Duan, J., Lv, A., Guo, Z., Liu, Q., Tian, C., Yang, Y., Bi, J., Yu, X., Peng, G., Luo, B., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03243-z · Cited by 22
“…EVs in peripheral blood could serve as potential diagnostic markers for various neurodegenerative diseases involving neuroinflammation [43, 44], we assessed their performance in patients with MS, HAM, AD, and PD. Remarkably, while alterations in microglial EVs were rather consistent in MS…”
BackgroundUnveiling microglia heterogeneity in intracerebral hemorrhage
Zhu, X., Xu, Z., Liu, Y., Yang, J. M., Bai, L., Li, X., Sun, Q., Li, H., & Chen, G. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.07.039 · Cited by 23
Shukla, S., Currim, F., Singh, J., Goyani, S., Saranga, M. V., Shinde, A., Mane, M., Chandak, N., Kishore, S., & Singh, R. K. (2023) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2023.106439 · Cited by 22
Li, S., Wu, J., Xing, X., Li, Y., Ma, J., Duan, Y.-J., Zhang, J., Shan, C., Hua, X., Zheng, M., et al. (2023) · Biological Research · doi:10.1186/s40659-023-00458-x · Cited by 22
The role of exosomes in the diagnosis of Parkinson's disease
Shi, Q., Kang, W., Liu, Z., & Zhu, X. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20595 · Cited by 22
Advancements in Targeting Macrophage Senescence for Age-Associated Conditions
Xiao, J., Li, H., Satyanarayanan, S. K., Leung, S. L., Yuan, Q., Wang, Y., Qin, D., & Lee, S. M.-Y. (2024) · Aging and Disease · doi:10.14336/ad.2024.0720 · Cited by 29
Versatile Copper-Chalcogenide-Based Nanoparticles for the Treatment of Brain Diseases
Xie, S., Liu, H., Yang, K., Wang, T., Zhang, H., & Li, Z. (2025) · Nano Biomedicine and Engineering · doi:10.26599/nbe.2025.9290117 · Cited by 24
Extracellular particles: emerging insights into central nervous system diseases
Chen, S., Bao, Q., Xu, W., & Zhai, X. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03354-6 · Cited by 23
Wei, M., Li, S., Yang, Z., Cheng, C., Li, T., & Le, W. (2021) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2021.102375 · Cited by 21
Li, A., Rastegar, C. T., & Mao, X. (2022) · Biomolecules · doi:10.3390/biom12070994 · Cited by 24
Reymond, S., Vujić, T., & Sanchez, J. (2022) · Biomedicines · doi:10.3390/biomedicines10092147 · Cited by 22
Exosomes in pathogenesis, diagnosis, and therapy of ischemic stroke
Jin, M., Zhang, S., Wang, M., Li, Q., Ren, J., Luo, Y., & Sun, X. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.980548 · Cited by 21
Shi, J., Wang, Y., Chen, D., Xu, X., Li, W., Li, K., He, J., Su, W., & Luo, Q. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12410-w · Cited by 23
P2X7 Receptor and Extracellular Vesicle Release
Golia, M. T., Gabrielli, M., & Verderio, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129805 · Cited by 22
Biology of Pellino1: a potential therapeutic target for inflammation in diseases and cancers
Yan, L., Cui, Y., & Feng, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1292022 · Cited by 22
Exosomes as Neurological Nanosized Machines
Pishavar, E., Trentini, M., Zanotti, F., Camponogara, F., Tiengo, E., Zanolla, I., Bonora, M., & Zavan, B. (2022) · ACS Nanoscience Au · doi:10.1021/acsnanoscienceau.1c00062 · Cited by 21
Hermann, D. M., Wang, C., Yusuf, A. M., Herz, J., Doeppner, T. R., & Giebel, B. (2025) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x251325039 · Cited by 22
Exosomal non-coding RNAs: gatekeepers of inflammation in autoimmune disease
Saadh, M. J., Allela, O. Q. B., Al-Hussainy, A. F., Baldaniya, L., Rekha, M. M., Nathiya, D., Kaur, P., Aminov, Z., Sameer, H. N., Hameed, H. G., et al. (2025) · Journal of Inflammation · doi:10.1186/s12950-025-00443-z · Cited by 22
Overcoming the Blood-Brain Barrier for Drug Delivery to the Brain
Katz, J. S., Slika, H., Sattari, S. A., Malla, A. P., Xia, Y., Antar, A., Ran, K. R., & Tyler, B. (2025) · ACS Omega · doi:10.1021/acsomega.5c00364 · Cited by 22
The emerging role of extracellular vesicles in viral transmission and immune evasion
Saleem, M., Chang, C., Qadeer, A., Asiri, M., Alzahrani, F. M., Alzahrani, K. J., Alsharif, K. F., Chen, C., & Hussain, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1634758 · Cited by 22
Huang, R., Gao, Y., Duan, Q., Zhang, Q., He, P., Chen, J., Ma, G., Wang, L., Zhang, Y., Nie, K., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03119-4 · Cited by 20
Tam, S., Wear, D., Morrone, C. D., & Yu, W. H. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16108 · Cited by 21
Tang, Y., Dong, M., Pang, X., Zhang, H., Chu, Y., Zhou, L., Yang, S., Zhang, L., You, Y., Zhu, L., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03281-7 · Cited by 20
Emerging Potential of Exosomal Non-coding RNA in Parkinson’s Disease: A Review
Zhang, P., Rasheed, M., Liang, J., Wang, C., Feng, L. P., & Chen, Z. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.819836 · Cited by 25
Zhai, L., Gao, Y., Yang, H., Wang, H., Liao, B., Cheng, Y., Liu, C., Che, J., Xia, K., Zhang, L., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123345 · Cited by 19
Impact of endolysosomal dysfunction upon exosomes in neurodegenerative diseases
Izco, M., Carlos, E., & Alvarez‐Erviti, L. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105651 · Cited by 19
Gong, Y., Dai, H., Liu, W., Liao, R., Chen, H., Zhang, L., Wang, X., & Chen, Z. (2023) · The FASEB Journal · doi:10.1096/fj.202200277r · Cited by 19
Microglia-derived exosomal circZNRF1 alleviates paraquat-induced neuronal cell damage via miR-17-5p
Liu, X., Wu, Q., Wu, J., Liu, J., Zheng, F., Yu, G., Hu, H., Guo, Z., Wu, S., Li, H., et al. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115356 · Cited by 19
Application of cell membrane-functionalized biomimetic nanoparticles in the treatment of glioma
Zhang, G., Yao, M., Ma, S., Zhang, K., Wang, Y., Wang, Z., Liang, J., Dai, S., Jin, R., & Guan, F. (2023) · Journal of Materials Chemistry B · doi:10.1039/d3tb00605k · Cited by 19
Zhang, S., Li, J., Hu, X., Liu, H., Yu, Q., Kuang, G., Liu, L., Yu, D., Lin, Z., & Xiong, N. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01262 · Cited by 20
Anagnostou, D., Sfakianaki, G., Melachroinou, K., Soutos, M., Constantinides, V. C., Vaikath, N. N., Tsantzali, I., Paraskevas, G. P., El‐Agnaf, O. M. A., Vekrellis, K., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13132192 · Cited by 19
Bartl, M., Nilsson, J., Dakna, M., Weber, S. K., Schade, S., Xylaki, M., Gomes, B. F., Ernst, M. S., Muntean, M., Sixel‐Döring, F., et al. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00714-1 · Cited by 19
Emerging role of microglia in inter-cellular transmission of α-synuclein in Parkinson’s disease
Zhang, X., Yu, H., & Feng, J. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1411104 · Cited by 19
Niskanen, J., Peltonen, S., Ohtonen, S., Fazaludeen, M. F., Luk, K. C., Giudice, L., Koıstınaho, J., Malm, T., Goldsteins, G., Albert, K., et al. (2024) · Glia · doi:10.1002/glia.24626 · Cited by 19
Glial cell crosstalk in Parkinson's disease: Mechanisms, implications, and therapeutic strategies
Wang, N., Xiao, X., Chen, Z., Xu, K., Cao, X., Kou, D., & Zeng, J. (2025) · Fundamental Research · doi:10.1016/j.fmre.2024.12.023 · Cited by 19
Exploring [11C]CPPC as a CSF1R-targeted PET imaging marker for early Parkinson’s disease severity
Mills, K. A., Du, Y., Coughlin, J. M., Foss, C. A., Horti, A. G., Jenkins, K. R., Skorobogatova, Y., Spiro, E., Motley, C., Dannals, R. F., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci186591 · Cited by 18
Rademacher, D. J. (2023) · Biomedicines · doi:10.3390/biomedicines11041187 · Cited by 14
Extracellular vesicles in TDP-43 proteinopathies: pathogenesis and biomarker potential
Dellar, E. R., Nikel, L., Fowler, S. L., Vahsen, B. F., Dafinca, R., Feneberg, E., Talbot, K., Turner, M. R., & Thompson, A. G. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00859-4 · Cited by 19
Yang, J., Tong, T., Zhu, C., Zhou, M., Jiang, Y., Chen, H., Que, L., Liu, L., Zhu, G., Ha, T., et al. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.09.004 · Cited by 17
Gan, Q., Ding, Y., Peng, M., Chen, L., Dong, J., Hu, J., & Ma, Y. (2023) · Biomolecules · doi:10.3390/biom13050873 · Cited by 17
Tang, X., He, Y., Liu, J., Xu, J., & Peng, Q. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.113938 · Cited by 17
Ashique, S., Kumar, N., Mishra, N., Muthu, S., Rajendran, R. L., Chandrasekaran, B., Obeng, B. F., Hong, C. M., Krishnan, A., Ahn, B., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155451 · Cited by 18
Extracellular vesicles‐based theranostics for neurodegenerative diseases
Zhao, H., Zhu, L., Wang, C., & Yang, Y. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1993 · Cited by 17
Shen, H., Chen, J., Liu, M., Zhao, M., Hu, D., Xie, F., Jin, Q., Xiao, D., Peng, Z., Qin, T., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1496304 · Cited by 23
Deng, Z., Chen, H., Chen, J., Du, Z., Zhou, W., & Yuan, Z. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167960 · Cited by 16
Salivary Exosomes in Health and Disease: Future Prospects in the Eye
Liu, A., Hefley, B. S., Escandon, P., Nicholas, S. E., & Karamichos, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076363 · Cited by 16
Extracellular Vesicles and Infection: From Hijacked Machinery to Therapeutic Tools
Gonçalves, D., Pinto, S. N., & Fernandes, F. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061738 · Cited by 18
Current progression in application of extracellular vesicles in central nervous system diseases
Zhang, X., Huang, J., Ni, X.-Y., Zhu, H.-R., Huang, Z., Ding, S., Yang, X., Tan, Y.-D., Chen, J., & Cai, J. (2024) · European journal of medical research · doi:10.1186/s40001-023-01606-5 · Cited by 17
Microglial exosomes in paraquat-induced Parkinson's disease: Neuroprotection and biomarker clues
Wu, J., Shao, W., Liu, X., Zheng, F., Wang, Y., Cai, P., Guo, Z., Hu, H., Yu, G., Guo, J., et al. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.124035 · Cited by 16
Plasma exosomes impair microglial degradation of α‐synuclein through V‐ATPase subunit V1G1
Li, Y., Wang, Y., Kou, L., Yin, S., Chi, X., Sun, Y., Wu, J., Jin, Z., Zhou, Q., Zou, W., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14738 · Cited by 19
Exosome technology: A novel and effective drug delivery system in the field of cancer therapy
Geng, J.-X., Lu, Y.-F., Zhou, J.-N., Huang, B., & Qin, Y. (2025) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v17.i3.101857 · Cited by 16
Towards physiologically relevant human pluripotent stem cell (hPSC) models of Parkinson’s disease
Coccia, E., & Ahfeldt, T. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02326-5 · Cited by 17
The Emerging Roles of Pellino Family in Pattern Recognition Receptor Signaling
Zhang, E., & Li, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.728794 · Cited by 19
Chen, B., Hasan, M. M., Zhang, H., Zhai, Q., Waliullah, A. S. M., Ping, Y., Zhang, C., Oyama, S., Mimi, M. A., Tomochika, Y., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11061685 · Cited by 16
Lau, V. Z., Awogbindin, I. O., Frenkel, D., Whitehead, S. N., & Tremblay, M. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70363 · Cited by 15
KIBRA regulates amyloid β metabolism by controlling extracellular vesicles secretion
Han, X., Wang, C., Song, L., Wang, X., Tang, S. H., Hou, T., Liu, C., Liang, X., Qiu, C., Wang, Y., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103980 · Cited by 15
Dai, M., Yan, L., Yu, H., Chen, C., & Xie, Y. (2023) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2023.102249 · Cited by 15
Bendig, J., Frank, A. K., & Reichmann, H. (2024) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2023.36 · Cited by 18
Exosomes in Vascular/Neurological Disorders and the Road Ahead
Alzahrani, F. A., Riza, Y. M., Eid, T. M., Almotairi, R., Scherschinski, L., Contreras, J., Nadeem, M., Perez, S. E., Raikwar, S. P., Jha, R. M., et al. (2024) · Cells · doi:10.3390/cells13080670 · Cited by 17
Modulating α-synuclein propagation and decomposition: Implications in Parkinson's disease therapy
Li, B., Xiao, X., Bi, M., Jiao, Q., Chen, X., Yan, C., Du, X., & Jiang, H. F. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102319 · Cited by 15
Zhu, Y., Wang, F., Xia, Y., Wang, L., Lin, H., Zhong, T., & Wang, X. (2024) · Reviews in the Neurosciences · doi:10.1515/revneuro-2024-0043 · Cited by 15
Yang, X., Gao, X., Jiang, X., Yue, K., & Luo, P. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00462 · Cited by 16
Xu, F.-F., Liu, Z., Fang, X., Cao, B., Huang, Y., Peng, Y.-P., & Qiu, Y.-H. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114089 · Cited by 18
Viral alpha-synuclein knockdown prevents spreading synucleinopathy
Menon, S. A., Kofoed, R. H., Nabbouh, F., Xhima, K., Al-Fahoum, Y., Langman, T., Mount, H. T. J., Shihabuddin, L. S., Sardi, S. P., Fraser, P. E., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab247 · Cited by 17
Bonaterra, G. A., Mierau, O., Hofmann, J., Schwarzbach, H., Aziz-Kalbhenn, H., Kolb, C., & Kinscherf, R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.603575 · Cited by 15
α-Synuclein in Parkinson's Disease: 12 Years Later
Vekrellis, K., Emmanouilidou, E., Xilouri, M., & Stefanis, L. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041645 · Cited by 16
Zhang, Y.-B., Liu, M., Wang, Y., Hu, D., Wu, S., Zhao, B., Zhou, B., & Yang, L. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177958 · Cited by 16
Role of OCT3 and DRP1 in the Transport of Paraquat in Astrocytes: A Mouse Study
Han, S., Feng, Y., Guo, M. A., Hao, Y., Sun, J., Zhao, Y., Dong, Q., Zhao, Y., & Cui, M. (2022) · Environmental Health Perspectives · doi:10.1289/ehp9505 · Cited by 14
Self-citationThe role of ACE2 in RAS axis on microglia activation in Parkinson’s disease
Liu, T., Li, J., Sun, L., Zhu, C., & Wei, J. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.06.024 · Cited by 14
Liu, Z., Cheng, L., Cao, W., Shen, C., Qiu, Y., Li, C., Xiong, Y., Yang, S., Chen, Z., Yin, X., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135826 · Cited by 14
Self-limiting multimerization of α-synuclein on membrane and its implication in Parkinson’s diseases
Ma, D., Zhang, S., Xu, S.-Y., Huang, Z., Tao, Y., Chen, F., Zhang, S., Li, D., Chen, T., Liu, C., et al. (2024) · Science Advances · doi:10.1126/sciadv.ado4893 · Cited by 14
The role of microglia in the prion-like transmission of protein aggregates in neurodegeneration
Öztürk, M. M., Emgård, J., García‐Revilla, J., Fernández‐Calle, R., Yang, Y., Deierborg, T., & Roos, T. T. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf087 · Cited by 17
Zhang, Q., Zheng, M., Sun, W., Loers, G., Wen, M., Wang, Q., Zheng, X., Siebert, H., Zhang, R., & Zhang, N. (2025) · Food & Function · doi:10.1039/d5fo00422e · Cited by 16
Song, N., Wang, X., Ha, L., Hu, L., Mei, S., Liang, Y., Zhao, Y., Yang, X., Zhang, Q., Zhou, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202503579 · Cited by 23
Self-citationGlial phagocytosis for synapse and toxic proteins in neurodegenerative diseases
Choi, Y., & Chung, W. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00870-9 · Cited by 16
Ji, W., Li, Y., Liu, R., Lü, Z., Liu, L., Shi, Z., Shen, J., & Zhang, X. (2021) · Materials Horizons · doi:10.1039/d0mh01542c · Cited by 14
Shan, L., Gao, H., Zhang, J., Li, W., Su, Y., & Guo, Y. (2022) · Talanta · doi:10.1016/j.talanta.2022.123560 · Cited by 14
Guo, M., Liu, W., Luo, H., Shao, Q., Li, Y., Gu, Y., Guan, Y., Ma, W., Chen, M., Yang, H., et al. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14055 · Cited by 14
Self-citationComprehensive data for studying serum exosome microRNA transcriptome in Parkinson’s disease patients
Yu, Z.-F., Saiki, S., Shiina, K., Iseki, T., Sasazawa, Y., Ishikawa, K., Nishikawa, N., Sako, W., Oyama, G., Hatano, T., et al. (2024) · Scientific Data · doi:10.1038/s41597-024-03909-6 · Cited by 15
Ghosh, S., & Ghosh, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.878058 · Cited by 13
Microglia–Neuron Crosstalk: An Intimate Molecular Conversation in Neurodegeneration
Wang, S., Wang, S., Hongzhuan, C. H. E. N., & Xu, J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27042011 · Cited by 13
Zheng, C., Zhao, W., Yang, Z., Tang, D.-E., Feng, M., & Guo, S.-X. (2023) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110873 · Cited by 11
A metabolomics study in aqueous humor discloses altered arginine metabolism in Parkinson’s disease
Serrano‐Marín, J., Marín, S., Bernal‐Casas, D., Lillo, A., González‐Subías, M., Navarro, G., Cascante, M., Sánchez-Navés, J., & Franco, R. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00494-5 · Cited by 14
⍺-Synuclein levels in Parkinson's disease – Cell types and forms that contribute to pathogenesis
Sagredo, G. T., Tanglay, O., Shahdadpuri, S., Fu, Y., & Halliday, G. M. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114887 · Cited by 14
Unveiling exosomal biomarkers in neurodegenerative diseases: LC-MS-based profiling
Bi, Y.-L., Wang, L., Li, C., Shan, Z. J., & Bi, L. (2025) · Extracellular Vesicle · doi:10.1016/j.vesic.2025.100071 · Cited by 14
Huang, W., Liu, Y., Li, J., Gao, Y., Tang, J., Yip, S., Wang, X., Zhang, H., Ma, Y., Su, S., et al. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.5.12 · Cited by 13
Neurodegeneration as Ecosystem Failure: A New Paradigm for Prevention and Treatment
Velikic, G. S., Šupić, G., Marić, D., Puletić, M., Kos, M. O., Vojvodić, D., & Maric, D. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211207 · Cited by 14
Muraoka, S., Lin, W., Takamatsu-Yukawa, K., Hu, J., Ikezu, S., Deture, M. A., Dickson, D. W., Emili, A., & Ikezu, T. (2021) · Aging and Disease · doi:10.14336/ad.2020.1007 · Cited by 13
Cholestanol accelerates α-synuclein aggregation and spreading by activating asparagine endopeptidase
Yu, T., Nie, S., Bu, L., Liu, M., He, J., Niu, X., Feng, H., Guo, J., Tang, B., Zhang, Z., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.165841 · Cited by 13
Samarpita, S., & Li, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087647 · Cited by 12
Bhatia, T. N., Jamenis, A. S., Abbas, M., Clark, R. N., Miner, K. M., Chandwani, M. N., Kim, R. E., Hilinski, W. C., O’Donnell, L. A., Luk, K. C., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106196 · Cited by 13
Mechanistic insights into connexin-mediated neuroglia crosstalk in neurodegenerative diseases
Denaro, S., D’Aprile, S., Vicario, N., & Parenti, R. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1532960 · Cited by 12
Almasi, F., Abbasloo, F., Soltani, N., Dehbozorgi, M., Fard, A. M., Kiani, A., Ghasemzadeh, N., Mesgari, H., Hosseingholi, E. Z., Payandeh, Z., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04788-7 · Cited by 13
Advancements in extracellular vesicle therapy for neurodegenerative diseases
Hu, N., Chen, L., Hu, G., & Ma, R. (2025) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2025.1004104 · Cited by 15
Metadata
- Authors
- Guo, M., Wang, J., Zhao, Y., Feng, Y., Han, S., Dong, Q., Cui, M., & Tieu, K.
- Affiliations
- Fudan University (CN)
- Tongji University (CN)
- Shanghai Medical College of Fudan University (CN)
- Florida International University (US)
- Corresponding author
- Dong, Qiang
- Cui, Mei
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-05-01
- Volume
- 143
- Issue
- 5
- Pages
- 1476-1497
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC7241957
- OpenAlex
- W3022628169
- Cited by
- 522
- References
- 70
- Citations by year
- 2026: 76 · 2025: 103 · 2024: 102 · 2023: 84 · 2022: 84 · 2021: 60 · 2020: 12
- FWCI
- 25.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Brain (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81971013, 81870915, 81571109, 81571232)
- Science and Technology Commission of Shanghai Municipality (16411970200)
- National Institute of Environmental Health Sciences (R01-ES022274, R35-ES030523)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- Parkinson's disease, alpha-synuclein, protein aggregation, prion-like spread, neuroinflammation, autophagy, PELI1, LAMP2, nigrostriatal degeneration, microglia depletion, therapeutic target
- MeSH terms
- Animals, Brain, Humans, Mice, Inbred C57BL, Neurons, Parkinson Disease, Microglia, Mice, alpha-Synuclein, Exosomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.